Message from the Chair
Autumn greetings from the Genomic Medicine Institute (GMI)! In acknowledgement of September’s World Alzheimer’s Month we have highlighted some of our research on Alzheimer disease and genetic counseling services at GMI.
Alzheimer disease (AD) is an all too common illness that is known for the toll it takes on patients and their loved ones. Whether you have a family history of AD or have it yourself our team of researchers, physicians and genetic counselors are dedicated to the early detection, treatment and future cure of this disease. The Center for Personalized Genetic Healthcare (CPGH), the clinical arm of the Genomic Medicine Institute, works closely with the Cleveland Clinic Neurologic Institute to serve patients with this particular disease.
In this issue, we share our research on biomarkers that could lead to early prediction and treatment to prevent the cognitive decline in Alzheimer’s patients and interview one of our own genetic counselors who sees patients with early on-set Alzheimer’s. We also share information about how technology is improving access to genetic counseling. Telegenetics and shared medical appointments are new avenues for patients to see a genetic counselor. In our education and outreach section we highlight and invite you to our upcoming, 4th Annual Genetic Education Symposium.
Click the links below for direct access to each article:
- Clinical Notes
- Education and Outreach
We appreciate your interest in genomics research and medicine. To learn more we encourage you to visit our website at http://www.lerner.ccf.org/gmi/.
Charis Eng, MD, PhD, FACP
American Cancer Society Clinical Research Professor
Sondra J and Stephen R Hardis Chair of Cancer Genomic Medicine
Chair, Genomic Medicine Institute
Director, Center for Personalized Genetic Healthcare